LCTC
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Lifeloc Technologies receives a Neutral rating with a moderate Composite score of 45.3, reflecting mixed performance across the pillars. With a fundamental pillar contribution leading at 53.0, regulatory close behind at 49.0, and declining engagement in market and editorial metrics, the current band indicates a cautious stance. The financial condition remains stretched, impacting the overall conviction which is set at a low 2 out of 5.
Financially, Lifeloc Technologies faces significant challenges, illustrated by sluggish year-over-year revenue growth hovering just above flat. The gross margin offers a glimpse of operational efficiency but is counterbalanced by negative operating margins, resulting in a net income that remains in deficit. The company's small market capitalization and modest cash burn ratio highlight incremental financial pressure, further underscored by the 'stretched' financial condition label provided by licensed fundamentals data. These elements combine to impact the fundamentals pillar score, which marginally outperforms the other metrics thanks to a relatively resilient cash runway position.
A critical factor moving forward lies within the regulatory environment, which presently exhibits a neutral jurisdictional posture in the U.S. The regulatory pillar, however, leads with no enforcement hits and favorable historical compliance records. Continual monitoring of regulatory filings, particularly any shifts in jurisdictional dynamics or enforcement landscapes, will be crucial. Keeping an eye on potential regulatory changes in the U.S. that could impact operational flexibility and market opportunities will provide insight into potential improvements in the company's prospects.
- IR email
- corporateinfo@lifeloc.com
- IR page
- Investor relations
- Headquarters
- 12441 WEST 49TH AVE UNIT #4, WHEAT RIDGE, CO, 80033
- Phone
- 303-431-9500
- CEO
- Wayne R. Willkomm
- CFO
- Vern D. Kornelsen
- SEC CIK
- 1493137
- Website
- Company website
- Market cap
- $9.6M
- Enterprise value
- $10.8M
- Price to book
- 2.42
- Price to sales
- 1.06
- EV / EBITDA
- 30.06
- Revenue (TTM)
- $9.0M
- Gross profit (TTM)
- $3.7M
- EBITDA
- $-669K
- Operating margin
- -5.6%
- Profit margin
- -25.8%
- Rev growth YoY
- 0.7%
- Return on equity
- -45.6%
- Return on assets
- -8.4%
- EPS (TTM)
- $-0.85
- Shares outstanding
- 2.8M
- Insider ownership
- 79.2%
- Beta
- 0.77
- Full-time employees
- 35
- GICS sector
- Technology
- GICS industry
- Scientific & Technical Instruments
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for LCTC (LCTC)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for LCTC (LCTC), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for LCTC are maintained by Cannabis Investor News and refreshed throughout the trading day.